Literature DB >> 1875945

Inducibility of the DNA repair gene encoding O6-methylguanine-DNA methyltransferase in mammalian cells by DNA-damaging treatments.

G Fritz1, K Tano, S Mitra, B Kaina.   

Abstract

The inducibility of the mammalian O6-methylguanine-DNA methyltransferase (MGMT) gene encoding the MGMT protein (EC 2.1.1.63) responsible for removal of the procarcinogenic and promutagenic lesion O6-alkylguanine from DNA was examined by an analysis of transcription of the MGMT gene following exposure of repair-competent (Mex+) and repair-deficient (Mex-) cells to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). While human and rodent Mex- cells (CHO-9, V79, HeLa MR) showed no detectable MGMT mRNA despite the presence of the gene in their genome, the amount of it in several Mex+ lines (NIH 3T3, HeLa S3, HepG2) paralleled their MGMT activity. However, none of these cell lines showed an increase in the MGMT mRNA level after treatment with various concentrations of MNNG. In contrast, MNNG-treated rat hepatoma cells, H4IIE and FTO-2B, both Mex+, had three- to fivefold more MGMT mRNA than the corresponding untreated controls as measured 12 to 72 h after alkylation. N-Methyl-N-nitrosourea, methyl methanesulfonate, N-hydroxyethyl-N-chloroethylnitrosourea, UV light, and X rays caused a similar accumulation of MGMT mRNA in rat hepatoma cells. Studies with inhibitors of RNA and protein synthesis indicate that the induced increase in the amount of MGMT mRNA was due to enhanced transcription of the gene. Furthermore, they revealed the turnover of the MGMT mRNA to be relatively low (half-life, greater than 7 h). Mutagen-induced increase of transcription of MGMT mRNA in H4IIE cells was accompanied by elevation of MGMT repair activity and resulted in reduction of mutation frequency after a challenge dose of MNNG. Although induction of MGMT mRNA transcription has been observed in two rodent hepatoma cell lines so far, this appears to be the first demonstration of inducibility of a mammalian gene encoding a clearly define DNA repair function. The transcription activation of the MGMT gene protects cells from the mutagenic effects of methylating agents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1875945      PMCID: PMC361355          DOI: 10.1128/mcb.11.9.4660-4668.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  Ionizing radiation regulates expression of the c-jun protooncogene.

Authors:  M L Sherman; R Datta; D E Hallahan; R R Weichselbaum; D W Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  The capacity of rat hepatoma cell lines for O6-methylguanine-DNA repair correlates with their status of differentiation.

Authors:  S Hesse; M Mezger; F J Wiebel
Journal:  Carcinogenesis       Date:  1984-07       Impact factor: 4.944

3.  Methylation of the O6 position of guanine in DNA is the most likely initiating event in carcinogenesis by methylating agents.

Authors:  A E Pegg
Journal:  Cancer Invest       Date:  1984       Impact factor: 2.176

4.  Repair of alkylated DNA in Escherichia coli. Physical properties of O6-methylguanine-DNA methyltransferase.

Authors:  B Demple; A Jacobsson; M Olsson; P Robins; T Lindahl
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

5.  Base-pairing properties of O6-methylguanine in template DNA during in vitro DNA replication.

Authors:  E T Snow; R S Foote; S Mitra
Journal:  J Biol Chem       Date:  1984-07-10       Impact factor: 5.157

6.  Lack of induction of O6-methylguanine-DNA methyltransferase in mammalian cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  R S Foote; S Mitra
Journal:  Carcinogenesis       Date:  1984-02       Impact factor: 4.944

7.  Repair of O6-methylguanine in DNA by demethylation is lacking in Mer- human tumor cell strains.

Authors:  D B Yarosh; R S Foote; S Mitra; R S Day
Journal:  Carcinogenesis       Date:  1983       Impact factor: 4.944

8.  O6-alkylguanine-DNA alkyltransferase activity in normal human tissues and cells.

Authors:  R C Grafstrom; A E Pegg; B F Trump; C C Harris
Journal:  Cancer Res       Date:  1984-07       Impact factor: 12.701

9.  Increased excision of O6-methylguanine from rat liver DNA after chronic administration of dimethylnitrosamine.

Authors:  R Montesano; H Brésil; G P Margison
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

10.  DNA repair and chromosomal stability in the alkylating agent-hypersensitive Chinese hamster cell line 27-1.

Authors:  B Kaina; A A van Zeeland; A de Groot; A T Natarajan
Journal:  Mutat Res       Date:  1990-03       Impact factor: 2.433

View more
  31 in total

1.  MGMT promoter methylation in non-neoplastic brain.

Authors:  Chih-Yi Hsu; Hsiang-Ling Ho; Yi-Chun Chang-Chien; Yi-Wen Chang; Donald Ming-Tak Ho
Journal:  J Neurooncol       Date:  2014-11-13       Impact factor: 4.130

2.  PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors.

Authors:  Brian McEllin; Cristel V Camacho; Bipasha Mukherjee; Brandon Hahm; Nozomi Tomimatsu; Robert M Bachoo; Sandeep Burma
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

3.  Labeling of fusion proteins with synthetic fluorophores in live cells.

Authors:  Antje Keppler; Horst Pick; Claudio Arrivoli; Horst Vogel; Kai Johnsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

Review 4.  Self-destruction and tolerance in resistance of mammalian cells to alkylation damage.

Authors:  P Karran; M Bignami
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

Review 5.  MGMT: a personal perspective.

Authors:  Sankar Mitra
Journal:  DNA Repair (Amst)       Date:  2007-05-07

6.  p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor.

Authors:  Dora Bocangel; Shiladitya Sengupta; Sankar Mitra; Kishor K Bhakat
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

7.  Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome.

Authors:  Shadi Lalezari; Arthur P Chou; Anh Tran; Orestes E Solis; Negar Khanlou; Weidong Chen; Sichen Li; Jose A Carrillo; Reshmi Chowdhury; Julia Selfridge; Desiree E Sanchez; Ryan W Wilson; Mira Zurayk; Jonathan Lalezari; Jerry J Lou; Laurel Ormiston; Karen Ancheta; Robert Hanna; Paul Miller; David Piccioni; Benjamin M Ellingson; Colin Buchanan; Paul S Mischel; Phioanh L Nghiemphu; Richard Green; He-Jing Wang; Whitney B Pope; Linda M Liau; Robert M Elashoff; Timothy F Cloughesy; William H Yong; Albert Lai
Journal:  Neuro Oncol       Date:  2013-01-17       Impact factor: 12.300

8.  Strategic down-regulation of DNA polymerase beta by antisense RNA sensitizes mammalian cells to specific DNA damaging agents.

Authors:  J K Horton; D K Srivastava; B Z Zmudzka; S H Wilson
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

9.  Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts.

Authors:  Gaspar J Kitange; Brett L Carlson; Mark A Schroeder; Patrick T Grogan; Jeff D Lamont; Paul A Decker; Wenting Wu; C David James; Jann N Sarkaria
Journal:  Neuro Oncol       Date:  2008-10-24       Impact factor: 12.300

10.  Ku80-Targeted pH-Sensitive Peptide-PNA Conjugates Are Tumor Selective and Sensitize Cancer Cells to Ionizing Radiation.

Authors:  Alanna R Kaplan; Ha Pham; Yanfeng Liu; Stanley Oyaghire; Raman Bahal; Donald M Engelman; Peter M Glazer
Journal:  Mol Cancer Res       Date:  2020-02-25       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.